Dana-Farber/Boston Children’s Cancer and Blood Disorder Center is happy to announce three research fellows have been named as part of the Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows.
Displaying 1-10 of 73 results matching:
Dana-Farber/Boston Children’s is honored to have 12 faculty members named part of Boston magazine’s “Top Doctors” for 2024.
Lisa Diller, MD, Chief Medical Officer at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, has been named an Innovator in Healthcare for Research by the Boston Business Journal.
Stuart H. Orkin, MD has been awarded the third Elaine Redding Brinster Prize in Science or Medicine for his landmark discoveries of the molecular basis of blood disorders and using the basic science findings for therapeutic approaches
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the #2 pediatric program in the nation in its 2023-24 Best Children's Hospitals report.
Boston magazine has named numerous Dana-Farber/Boston Children’s Cancer and Blood Disorders Center faculty members to its annual "Top Doctors" guide.
After an extensive national search, it is with great pleasure that Dana-Farber/Boston Children's Cancer and Blood Disorders Center introduces Abby R. Rosenberg, MD, MS, MA, as the new Chief of Pediatric Palliative Care at Dana-Farber Cancer Institute and Director of Palliative Care at Boston Children’s Hospital.
Children diagnosed with diffuse midline gliomas often die within a year after their initial diagnosis since there are no effective treatments yet for this rare cancer. But researchers now have a better understanding of what these tumors look like and can work towards developing new treatment approaches.
Many US families of children with leukemia may experience food insecurity, according to results presented at the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.